Testing AP306 for high phosphate in dialysis patients
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medication called AP306 for people on hemodialysis who have high blood phosphate. It aims to see if the drug is safe, tolerable, and helps lower phosphate levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on hemodialysis (blood cleaning) three times a week for at least 12 weeks.
- Your blood phosphate level is too high.
- Your dialysis is working well, as shown by a recent blood test.
- Your medications (like phosphate binders) have been at the same dose for at least 2 weeks.
- You are not planning a kidney transplant, changing dialysis type, or relocating centers during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called AP301 to lower high phosphate levels in people on dialysis. It's designed to help control phosphate, which can be hard to manage with diet and current medications.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This trial tests a new medicine called TS-172 for people with high phosphorus levels who are on hemodialysis. It aims to lower phosphorus levels and is taken along with your current phosphate binder medication.
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
Hear when a new Hyperphosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.